Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 1/17/2026

Contact Dermatitis Management

Introduction to Contact Dermatitis

  • The American Academy of Dermatology recommends identifying and avoiding the causative agent, applying topical corticosteroids for inflammation, and using moisturizers to repair the skin barrier as the most effective treatment for contact dermatitis 1, 2

Diagnosis and Assessment

  • The British Association of Dermatologists suggests that pattern and morphology of dermatitis, especially on hands and face, is unreliable in distinguishing between irritant, allergic, or endogenous dermatitis 3
  • A detailed history should include initial location of symptoms and spread pattern, relationship to specific products or activities, and occupational and recreational exposures, as recommended by the British Association of Dermatologists 3
  • Patch testing is recommended for persistent cases to identify specific allergens, according to the British Association of Dermatologists 2, 4

Treatment of Irritant Contact Dermatitis

  • The American Academy of Dermatology recommends identifying and avoiding irritants, using soap substitutes and gentle cleansers, and applying moisturizers immediately after washing hands to repair skin barrier 1, 5, 6
  • Topical corticosteroids should be applied if conservative measures fail, with consideration of potential steroid-induced damage to skin barrier with prolonged use, as suggested by the American Academy of Dermatology 1

Treatment of Allergic Contact Dermatitis

  • The British Association of Dermatologists recommends identifying allergens through patch testing and ensuring complete avoidance, and applying topical corticosteroids to mitigate flares of dermatitis 4, 1
  • For severe or recalcitrant cases, stronger topical steroids, phototherapy, or systemic immunosuppressants like azathioprine or ciclosporin may be considered, according to the British Association of Dermatologists 1, 4

Protective Measures

  • The American Academy of Dermatology suggests that appropriate gloves provide protection for hand dermatitis, and recommends using rubber or PVC gloves with cotton liners for household tasks 1, 5
  • Removing gloves regularly and applying moisturizer before wearing gloves can help prevent dermatitis, as recommended by the American Academy of Dermatology 1, 5

Moisturizers and Barrier Creams

  • The American Academy of Dermatology recommends using moisturizers packaged in tubes rather than jars to prevent contamination, and applying two fingertip units of moisturizer to hands after washing 1, 6
  • Barrier creams alone have questionable value in protecting against irritants, but after-work creams have shown benefit in reducing irritant contact dermatitis, according to the British Association of Dermatologists 7, 8

Special Considerations

  • The British Association of Dermatologists suggests that for occupational dermatitis, workplace assessment may be necessary to identify all potential hazards, and prognosis for occupational contact dermatitis is often poor 5, 7
  • Patients with recalcitrant hand dermatitis should seek dermatology consultation, and nickel-sensitive patients may benefit from low-nickel diets in some cases, as recommended by the American Academy of Dermatology and the British Association of Dermatologists 1, 4

Common Pitfalls to Avoid

  • The American Academy of Dermatology recommends avoiding washing hands with dish detergent or other known irritants, very hot or very cold water, disinfectant wipes, and products containing topical antibiotics, as well as excessive occlusion without underlying moisturizer application 1
  • The British Association of Dermatologists suggests avoiding over-promotion of barrier creams as they may give false sense of security 8

Contact Dermatitis Treatment Guidelines

Introduction to Treatment

  • The British Journal of Dermatology recommends applying topical corticosteroids as the cornerstone of acute treatment, with soap substitutes and emollients forming the foundation of established contact dermatitis management 9
  • After-work creams have demonstrated benefit in reducing irritant contact dermatitis incidence and should be readily available in workplace settings 9

Protective Measures

  • Remove gloves regularly to prevent sweat accumulation, which can aggravate dermatitis, as recommended by the British Journal of Dermatology 9
  • In occupational settings, select gloves based on specific chemical exposures and consider permeation time, as "impervious" gloves have finite protection duration, according to the British Journal of Dermatology 9
  • Barrier creams alone have questionable value and should not be over-promoted, as they may create false security and reduce implementation of appropriate preventive measures, as stated by the British Journal of Dermatology 9

Advanced Therapies

  • For steroid-resistant chronic hand dermatitis, consider psoralen plus UVA (PUVA), azathioprine, or ciclosporin, all supported by prospective clinical trials, as recommended by the British Journal of Dermatology 9
  • Topical tacrolimus has shown effectiveness in nickel-induced allergic contact dermatitis models, according to the British Journal of Dermatology 9
  • Combined topical corticosteroid/antibiotic combinations show marginal benefit in infected or potentially infected eczema, as reported by the British Journal of Dermatology 9

Special Populations

  • Workplace visits are essential for identifying potential allergens and irritants and are critical for effective treatment and prevention, as emphasized by the British Journal of Dermatology 9
  • Prognosis for occupational contact dermatitis is often poor: only 25% of patients achieve complete healing, with 50% having periodic symptoms and 25% having permanent symptoms, according to the British Journal of Dermatology 9
  • Changing occupation does not improve prognosis in 40% of cases, as stated by the British Journal of Dermatology 9

Diagnostic Considerations

  • Patients should be patch tested to at least an extended standard series of allergens, as recommended by the British Journal of Dermatology 9
  • Do not apply potent topical steroids to the back within 2 days of patch testing, as this causes false negatives, according to the British Journal of Dermatology 9
  • Avoid oral corticosteroids or immunosuppressants during patch testing; if unavoidable, keep prednisolone ≤10 mg daily, as advised by the British Journal of Dermatology 9

Treatment of Acute Contact Dermatitis

Introduction to Management

  • The American Academy of Dermatology recommends using moisturizers packaged in tubes rather than jars to prevent contamination, and applying two fingertip units of moisturizer to hands after each washing, with the "soak and smear" technique: soak hands in plain water for 20 minutes, then immediately apply moisturizer to damp skin nightly for up to 2 weeks 10
  • The British Association of Dermatologists notes that acute phase contact dermatitis is characterized by erythema and vesiculation, while chronic phase is characterized by dryness, lichenification, and fissuring 11, 12

Distinguishing Irritant vs. Allergic Contact Dermatitis

  • Irritant contact dermatitis results from single overwhelming exposure or repetitive exposure to weaker irritants, such as detergents, solvents, or soaps, according to the British Association of Dermatologists 13, 11

Protective Measures During Treatment

  • The American Academy of Dermatology suggests applying moisturizer before wearing gloves, and using accelerator-free gloves such as rubber-free neoprene or nitrile gloves for glove-related allergic contact dermatitis 10
  • Latex, vinyl, and nitrile gloves are resistant to breakdown from ethanol or isopropyl alcohol, as noted by the American Academy of Dermatology 10

Critical Pitfalls to Avoid

  • The American Academy of Dermatology advises against washing hands with dish detergent or other known irritants, using very hot or very cold water for hand washing, using disinfectant wipes to clean hands, and applying products containing topical antibiotics without indication 10
  • Prolonged occlusion without underlying moisturizer application should be avoided, according to the American Academy of Dermatology 10

Advanced Treatment Options for Refractory Cases

  • The British Association of Dermatologists recommends considering topical tacrolimus where topical steroids are unsuitable or ineffective, and offering alitretinoin for severe chronic hand eczema 11, 12

Management of Persistent Contact Dermatitis

Introduction to Treatment

  • The American Academy of Dermatology recommends escalating to very high potency topical corticosteroids, such as clobetasol propionate 0.05%, for 2 weeks in patients with persistent contact dermatitis on the abdomen that has failed hydrocortisone and betamethasone valerate 0.1% 14
  • Very high potency topical corticosteroids achieve clear or almost clear skin in 67.2% of patients with severe dermatitis, compared to 22.3% with vehicle, over a 2-week period 14
  • Adverse events with very high potency steroids are low, with fewer withdrawals in treatment groups (0.8%) compared to vehicle groups (11.3%) over 2-week treatment periods 14

Allergen Avoidance and Identification

  • The British Association of Dermatologists recommends referring patients for patch testing to identify specific allergens, including testing for corticosteroid allergy, to guide complete avoidance 15, 16
  • Replace all soaps and detergents with emollients, as these are common irritants that can perpetuate dermatitis, and substitute materials in contact with the abdomen, such as using fragrance-free detergents and avoiding metal belt buckles if nickel-sensitive 15, 16
  • Apply moisturizers liberally to restore skin barrier function, with a recommended amount of 100g per 2 weeks for the trunk area 17

Second-Line Therapies

  • The British Association of Dermatologists suggests considering topical tacrolimus or referring for systemic therapies if dermatitis persists despite high-potency steroids and allergen avoidance 15, 16
  • Topical tacrolimus 0.1% is effective for contact dermatitis and avoids the risk of corticosteroid allergy 15, 16
  • Phototherapy, such as PUVA, is an established second-line treatment for chronic contact dermatitis 15, 16

Prognosis

  • The British Association of Dermatologists notes that persistent contact dermatitis has a poor prognosis, with only 25% of patients achieving complete healing over 10 years 15, 16
  • 50% of patients will have intermittent symptoms and 25% will have permanent symptoms despite treatment 15, 16
  • Early identification and complete avoidance of allergens offers the best chance for resolution 15, 16

Treatment of Contact Dermatitis with Unknown Cause

Initial Management and Diagnostic Approach

  • The British Association of Dermatologists recommends beginning with aggressive emollient therapy and mid-to-high potency topical corticosteroids while simultaneously pursuing allergen identification through patch testing for patients with unknown cause of contact dermatitis 18
  • Refer for patch testing to at least an extended standard series of allergens to identify the causative agent, as pattern and morphology alone are unreliable in distinguishing between irritant, allergic, or endogenous dermatitis, according to the British Association of Dermatologists 18, 19
  • Consider workplace visit if occupational exposure is suspected, to identify hidden allergens and assess procedures that may cause accidental exposure, as suggested by the British Association of Dermatologists 18, 19

Protective Measures and Treatment Escalation

  • Use appropriate protective gloves based on suspected exposures, such as rubber or PVC gloves with cotton liners for household tasks, with regular removal to prevent sweat accumulation, as recommended by the British Association of Dermatologists 18, 19
  • Do not over-rely on barrier creams alone, as they have questionable value in protecting against irritants and may create false security, according to the British Association of Dermatologists 18, 19
  • Phototherapy (PUVA) is an established second-line treatment for chronic contact dermatitis resistant to topical steroids, as supported by the British Association of Dermatologists 18

Treatment of Cutaneous Drug Eruption and Allergic Contact Dermatitis

Diagnostic Considerations

  • The British Journal of Dermatology recommends referring for patch testing with an extended standard series of allergens if dermatitis persists despite treatment or if the causative agent remains unknown, with a focus on distinguishing between irritant, allergic, or endogenous dermatitis 20, 21
  • Pattern and morphology of dermatitis, particularly on hands and face, is unreliable in distinguishing between irritant, allergic, or endogenous dermatitis, according to the British Journal of Dermatology 21

Second-Line Therapies for Refractory Cases

  • The British Journal of Dermatology suggests considering topical tacrolimus 0.1% or pimecrolimus 1% where topical steroids are unsuitable, ineffective, or when chronic facial dermatitis raises concerns about steroid-induced skin damage, with alitretinoin offered for severe chronic hand eczema 20, 21
  • The Journal of Allergy and Clinical Immunology notes that for NSAID-induced contact dermatitis, cross-reactivity within the same chemical class is well described; avoid topical and systemic administration of molecules in the sensitizing class 22

Protective Measures

  • The British Journal of Dermatology recommends using appropriate gloves based on specific exposures—rubber or PVC gloves with cotton liners for household tasks, neoprene or nitrile for latex allergy, and selecting gloves based on chemical exposures and considering permeation time in occupational settings 20
  • The American Academy of Dermatology advises exercising extreme caution with topical corticosteroids on facial skin—prolonged use causes skin thinning, telangiectasia, perioral dermatitis, and red face syndrome, due to increased percutaneous absorption 23

Contact Dermatitis Diagnosis and Treatment

Distinguishing Between Irritant and Allergic Contact Dermatitis

  • Clinical features alone are unreliable in distinguishing between irritant and allergic contact dermatitis, particularly on hands and face, making patch testing essential when the diagnosis remains uncertain, as recommended by the British Journal of Dermatology 24
  • Allergic contact dermatitis involves delayed-type hypersensitivity (Type IV) to specific allergens like nickel, fragrances, preservatives, or rubber chemicals, requiring prior sensitization, according to the Journal of the American Academy of Dermatology and the British Journal of Dermatology 25, 24

Second-Line Therapies for Refractory Cases

  • Consider topical tacrolimus 0.1% where topical steroids are unsuitable, ineffective, or when chronic facial dermatitis raises concerns about steroid-induced skin damage, as suggested by the British Journal of Dermatology 24
  • PUVA phototherapy is an established second-line treatment for chronic hand eczema resistant to topical steroids, according to the British Journal of Dermatology 24
  • For severe chronic hand eczema, alitretinoin is recommended by the British Association of Dermatologists, as reported in the British Journal of Dermatology 24
  • The British Journal of Dermatology also notes that a small subset of patients may develop allergic contact dermatitis to topical corticosteroids themselves, requiring patch testing to corticosteroid allergens, which is supported by the Journal of the American Academy of Dermatology 25, 24

Treatment of Contact Dermatitis

Introduction to Management

  • The British Association of Dermatologists recommends the cornerstone of contact dermatitis treatment is complete avoidance of the causative allergen or irritant combined with mid-to-high potency topical corticosteroids and aggressive emollient therapy 26

Diagnostic Steps

  • Obtain patch testing with an extended baseline series of allergens for any persistent or chronic dermatitis, as clinical features alone cannot reliably distinguish between irritant, allergic, or endogenous dermatitis, particularly on hands and face, as suggested by the British Journal of Dermatology 26

First-Line Therapies

  • Replace all soaps and detergents with emollients immediately, even if they are not the identified cause, as these are universal irritants that perpetuate inflammation, according to the British Journal of Dermatology 27, 28
  • For occupational cases, arrange workplace visits to identify hidden allergens, assess procedures causing accidental exposure, and review Material Safety Data Sheets, as recommended by the British Journal of Dermatology 29, 28

Protective Measures

  • Select gloves based on specific chemical exposures and check Material Safety Data Sheets for permeation times—no glove is completely impermeable, as advised by the British Journal of Dermatology 26, 27
  • For general household tasks, use rubber or PVC gloves with cotton liners, as suggested by the British Journal of Dermatology 26, 28
  • Do not over-rely on barrier creams alone—they have questionable clinical value in workplace settings and may create false security, reducing implementation of appropriate preventive measures, according to the British Journal of Dermatology 27

Second-Line Therapies

  • Consider topical tacrolimus 0.1% where topical steroids are unsuitable, ineffective, or when chronic facial dermatitis raises concerns about steroid-induced damage, as recommended by the British Journal of Dermatology 26, 28
  • Consider PUVA (psoralen plus UVA) therapy for chronic hand eczema resistant to topical steroids, supported by prospective clinical trials, as suggested by the British Journal of Dermatology 26, 28
  • Offer alitretinoin specifically for severe chronic hand eczema (strong recommendation), as advised by the British Journal of Dermatology 26

Patient Education and Prognosis

  • Implement comprehensive educational programs for occupational contact dermatitis, which demonstrate improvements in established hand dermatitis and prevention of new cases, as recommended by the British Journal of Dermatology 27, 28
  • Provide written information on patch testing, including potential side-effects, and obtain informed consent, as suggested by the British Journal of Dermatology 26
  • The long-term prognosis for occupational contact dermatitis is poor: only 25% achieve complete healing over 10 years, 50% have intermittent symptoms, and 25% have permanent symptoms, according to the British Journal of Dermatology 29, 27
  • Changing occupation does not improve prognosis in 40% of cases, as reported by the British Journal of Dermatology 29, 27
  • Use clinical assessment tools (Dermatology Life Quality Index, Hand Eczema Severity Index) for initial assessment and monitoring treatment response, as recommended by the British Journal of Dermatology 26
  • Do not recommend exclusion diets—no good-quality studies support their use in contact dermatitis management, as advised by the British Journal of Dermatology 29, 27

Contact Dermatitis Management

Introduction to Treatment

  • The British Journal of Dermatology recommends replacing all soaps and detergents with emollients immediately, as these are universal irritants that perpetuate inflammation, and substituting different materials both in workplace and home environments, such as thiuram-free gloves and isothiazolinone-free creams/cleansers 30
  • The British Journal of Dermatology suggests that barrier creams have questionable clinical value and may create false security, reducing implementation of appropriate preventive measures, but after-work creams have demonstrated benefit in reducing irritant contact dermatitis incidence 30
  • The British Journal of Dermatology recommends considering topical tacrolimus 0.1% where topical steroids are unsuitable, ineffective, or when chronic facial dermatitis raises concerns about steroid-induced skin damage, and notes that topical tacrolimus has demonstrated effectiveness in allergic contact dermatitis models 30
  • The British Journal of Dermatology supports the use of PUVA (psoralen plus UVA) therapy as an established second-line treatment for chronic hand eczema resistant to topical steroids, based on prospective clinical trials 30
  • The British Journal of Dermatology recommends considering methotrexate, mycophenolate mofetil, azathioprine, or ciclosporin for steroid-resistant chronic contact dermatitis, and specifically recommends alitretinoin for severe chronic hand eczema (strong recommendation) 30
  • The British Journal of Dermatology suggests that comprehensive educational programs for occupational contact dermatitis demonstrate improvements in established hand dermatitis and prevention of new cases, and notes that the long-term prognosis for occupational contact dermatitis is poor, with only 25% achieving complete healing over 10 years 30

Contact Dermatitis Treatment Guidelines

First-Line Treatment

  • The British Journal of Dermatology recommends complete avoidance of the causative allergen or irritant combined with mid-to-high potency topical corticosteroids and aggressive emollient therapy for contact dermatitis treatment 31
  • Replace all soaps and detergents with emollients immediately, as these are universal irritants that perpetuate inflammation, according to the British Journal of Dermatology 31
  • Select gloves based on specific chemical exposures and check Material Safety Data Sheets for permeation times—no glove is completely impermeable, as suggested by the British Journal of Dermatology 31
  • For general household tasks, use rubber or PVC gloves with cotton liners, as recommended by the British Journal of Dermatology 31

Diagnostic Workup

  • Obtain patch testing with an extended baseline series of allergens for any persistent or chronic dermatitis, as clinical features alone cannot reliably distinguish between irritant, allergic, or endogenous dermatitis, particularly on hands and face, according to the British Journal of Dermatology 31

Protective Measures and Substitution

  • Use thiuram-free gloves for rubber chemical allergy, as recommended by the British Journal of Dermatology 31
  • Change biocides in industrial coolant oils for occupational exposures, as suggested by the British Journal of Dermatology 31
  • Use isothiazolinone-free creams/cleansers for preservative allergy, according to the British Journal of Dermatology 31

Second-Line Therapies

  • Consider topical tacrolimus 0.1% where topical steroids are unsuitable, ineffective, or when chronic facial dermatitis raises concerns about steroid-induced skin damage, as recommended by the British Journal of Dermatology 31
  • PUVA (psoralen plus UVA) therapy is an established second-line treatment for chronic hand eczema resistant to topical steroids, supported by prospective clinical trials, according to the British Journal of Dermatology 31
  • Consider methotrexate, mycophenolate mofetil, azathioprine, or ciclosporin for steroid-resistant chronic contact dermatitis, as suggested by the British Journal of Dermatology 31
  • For severe chronic hand eczema specifically, offer alitretinoin (strong recommendation), according to the British Journal of Dermatology 31

Occupational Contact Dermatitis

  • Arrange workplace visits to identify hidden allergens, assess procedures causing accidental exposure, and review Material Safety Data Sheets, as recommended by the British Journal of Dermatology 31
  • Implement comprehensive educational programs for occupational contact dermatitis, which demonstrate improvements in established hand dermatitis and prevention of new cases, according to the British Journal of Dermatology 31
  • Compliance with skin-protection programs is often poor, requiring ongoing reinforcement, as noted by the British Journal of Dermatology 31
  • The long-term prognosis for occupational contact dermatitis is poor: only 25% achieve complete healing over 10 years, 50% have intermittent symptoms, and 25% have permanent symptoms, according to the British Journal of Dermatology 31
  • Changing occupation does not improve prognosis in 40% of cases, as reported by the British Journal of Dermatology 31

What to Avoid

  • Do not recommend exclusion diets—no good-quality studies support their use in contact dermatitis management, according to the British Journal of Dermatology 31

Management of Mild Contact Dermatitis

Topical Treatment and Protective Measures

  • The American Academy of Dermatology recommends using soap-free shower gel and/or bath oil, avoiding alcoholic solutions entirely, to manage mild contact dermatitis 32
  • The National Eczema Association suggests applying urea- or glycerin-based moisturizers liberally to restore barrier function in patients with mild contact dermatitis 32

Reassessment and Escalation

  • The European Academy of Dermatology and Venereology advises reassessing patients after 2 weeks of treatment, and if worsening or no improvement occurs, escalating to moderate-grade treatment protocols 32
  • The American College of Dermatology recommends continuing EGFR inhibitor therapy during mild skin reactions while implementing topical management, and considering oral antihistamines for pruritus associated with mild contact dermatitis 32

Evidence‑Based Recommendations for Glove Use and Systemic Steroid Side Effects in Contact Dermatitis Management

Protective Measures – Hand Protection

  • For patients with extensive contact dermatitis receiving systemic corticosteroid therapy, use rubber or PVC gloves with cotton liners for household tasks and remove them regularly to prevent sweat accumulation, which can exacerbate skin irritation. 33

Monitoring for Systemic Steroid‑Related Side Effects

  • Systemic corticosteroid injections may cause mood changes or irritability in adults undergoing treatment for widespread contact dermatitis. 33
  • Elevated blood glucose levels can occur after systemic corticosteroid administration, particularly in individuals with pre‑existing diabetes, highlighting the need for glucose monitoring during therapy. 33

Unilateral Hand Dermatitis: Evidence‑Based Evaluation and Management

Diagnostic Significance of Unilateral Presentation

  • Unilateral hand dermatitis strongly indicates a localized external exposure rather than systemic or constitutional skin disease, making asymmetric involvement a key diagnostic clue. (CDC MMWR Recommendations, 2002) 34 – Evidence level: not specified
  • The unilateral distribution alone cannot reliably distinguish irritant from allergic contact dermatitis; additional history and testing are required. (CDC MMWR Recommendations, 2002) 34 – Evidence level: not specified

Exposure History – Common Unilateral Triggers

Occupational / Habitual Exposures

  • Dominant‑hand use of specific tools, chemicals, or wet work is a frequent source of unilateral dermatitis. (CDC MMWR Recommendations, 2002) 34 – Evidence level: not specified

Household & Personal Care Exposures

  • Cleaning agents, dish detergents, gardening chemicals, and hobby‑related materials are common irritants that can affect only the hand most frequently used. (American Academy of Dermatology, 2020) 35 – Evidence level: not specified
  • Excessive hand washing, frequent use of alcohol‑based hand sanitizers, and application of disinfectant wipes on one hand markedly increase dermatitis risk. (American Academy of Dermatology, 2020) 35 – Evidence level: not specified
  • Wearing a glove on only one hand or exposure to rubber/latex gloves can precipitate unilateral dermatitis. (American Academy of Dermatology, 2020) 35 – Evidence level: not specified

First‑Line Treatment

Aggressive Moisturization

  • Apply two fingertip units of a fragrance‑free moisturizer containing petrolatum or mineral oil immediately after each hand wash; reapply every 3–4 hours and after every wash. (American Academy of Dermatology, 2020) 36 – Evidence level: not specified
  • Use the “soak‑and‑smear” method: soak the affected hand in plain water for ≈20 minutes, then apply moisturizer to damp skin nightly for up to 2 weeks. (American Academy of Dermatology, 2020) 36 – Evidence level: not specified
  • Prefer moisturizers packaged in tubes rather than jars to minimize contamination. (American Academy of Dermatology, 2020) 36 – Evidence level: not specified

Topical Corticosteroid Considerations

  • Prolonged use of potent topical steroids may damage the skin barrier; clinicians should monitor for steroid‑induced barrier impairment. (American Academy of Dermatology, 2020) 35 – Evidence level: not specified

Irritant Avoidance Strategies

  • Wash hands with lukewarm or cool water; water temperatures > 40 °C increase lipid fluidization and skin permeability, worsening dermatitis. (American Academy of Dermatology, 2020) 36 – Evidence level: not specified
  • Do not use dish detergent or other known irritants for hand washing. (American Academy of Dermatology, 2020) 36 – Evidence level: not specified
  • Disinfectant wipes designed for surfaces contain harsh antimicrobials (e.g., N‑alkyl dimethyl benzyl ammonium chloride) and should not be applied to skin. (American Academy of Dermatology, 2020) 35 – Evidence level: not specified

Protective Measures During Ongoing Therapy

  • Apply moisturizer before donning gloves to reduce occlusion‑related irritation. (American Academy of Dermatology, 2020) 36 – Evidence level: not specified
  • For household tasks, use rubber or PVC gloves with cotton liners and remove them regularly to prevent sweat accumulation. (CDC MMWR Recommendations, 2002) 34 – Evidence level: not specified
  • In patients with latex allergy, select accelerator‑free neoprene or nitrile gloves. (American Academy of Dermatology, 2020) 36 – Evidence level: not specified

Critical Pitfalls to Avoid

  • Do not wash hands immediately before or after using alcohol‑based hand sanitizer; this practice unnecessarily increases dermatitis risk. (American Academy of Dermatology, 2020) 36 – Evidence level: not specified
  • Do not apply gloves while hands are still wet from washing or sanitizer. (American Academy of Dermatology, 2020) 36 – Evidence level: not specified
  • Do not use very hot or very cold water for hand washing, as extreme temperatures exacerbate barrier disruption. (American Academy of Dermatology, 2020) 36 – Evidence level: not specified
  • Do not rely solely on barrier creams; their clinical benefit is questionable and may give a false sense of security. (CDC MMWR Recommendations, 2002) 34 – Evidence level: not specified
  • Avoid topical antibiotics (e.g., neomycin, bacitracin) without clear indication, since they are frequent contact allergens. (American Academy of Dermatology, 2020) 36 – Evidence level: not specified

Pathophysiology: Irritant vs. Allergic Contact Dermatitis

  • Irritant contact dermatitis (ICD) accounts for ≈80 % of occupational skin disease cases, making it the predominant form of hand dermatitis in work‑related settings. (American Academy of Dermatology, 2020) 35 – Evidence level: not specified
  • ICD arises from direct chemical or physical damage to the skin barrier by detergents, solvents, or repeated wet work. (American Academy of Dermatology, 2020) 35 – Evidence level: not specified
  • Allergic contact dermatitis (ACD) requires prior sensitization to a specific allergen, followed by elicitation upon re‑exposure. (American Academy of Dermatology, 2020) 35 – Evidence level: not specified
  • Rubber accelerators present in gloves are among the most common allergens implicated in unilateral hand dermatitis. (American Academy of Dermatology, 2020) 35 – Evidence level: not specified

All facts above are derived from peer‑reviewed sources with citation IDs as indicated.

Evidence‑Based Management of Acute Contact Dermatitis in Children

Systemic Corticosteroid Therapy

  • Systemic corticosteroids have a limited but definite role in severe acute contact dermatitis and should not be used for maintenance treatment until all other therapeutic options have been exhausted. 37, 38

Antihistamine Use

  • Oral antihistamines (e.g., diphenhydramine) are recommended as adjuvant therapy to reduce pruritus in contact dermatitis, primarily because of their sedative effect. 39, 37, 38
  • Sedating antihistamines are useful short‑term during acute flares with severe itching, especially for nighttime use to facilitate sleep. 37, 38
  • Non‑sedating antihistamines provide little or no benefit in the management of contact dermatitis. 37, 38
  • In children, higher doses of antihistamines may be required to achieve adequate symptom control. 37, 38
  • The therapeutic effect of antihistamines may diminish over time due to tachyphylaxis with continued use. 37, 38

Topical Corticosteroid Guidelines

  • For pediatric patients, lower‑potency topical corticosteroids should be chosen compared with adult regimens because children have a higher risk of adrenal suppression and systemic absorption through thinner skin. 39
  • The duration of potent topical corticosteroids on highly sensitive areas (face, neck, skin folds) must be limited to avoid skin atrophy, telangiectasia, perioral dermatitis, and “red‑face” syndrome. 39
  • Topical corticosteroids should be applied no more than twice daily; some newer formulations are effective with once‑daily application. 37, 38

Moisturization (Emollient) Strategy

  • Regular use of fragrance‑free moisturizers provides both short‑ and long‑term steroid‑sparing effects in contact dermatitis. 39

Second‑Line Therapies for Refractory Cases

  • Wet‑wrap therapy with topical corticosteroids is an effective and relatively safe short‑term option (3–7 days, up to 14 days) for moderate to very severe contact dermatitis that does not respond to conventional treatment. 39
  • Topical calcineurin inhibitors (tacrolimus 0.1 % or pimecrolimus 1 %) may be used when topical steroids are unsuitable, ineffective, or when chronic facial involvement raises concerns about steroid‑induced skin damage. 39
  • Phototherapy is not recommended for children younger than 12 years because the long‑term safety profile remains uncertain. 39

Safety and Critical Pitfalls

  • Long‑term systemic corticosteroids should be avoided for maintenance due to an unfavorable risk‑benefit profile, including potential growth suppression and hypothalamic‑pituitary‑adrenal axis inhibition in children. 39, 37, 38
  • Topical antihistamines lack sufficient evidence for efficacy and may themselves provoke contact dermatitis; they should be avoided. 39
  • Routine use of topical antibiotics is discouraged; they should be reserved for confirmed secondary bacterial infection because agents such as neomycin and bacitracin are common contact allergens. 39

Prognosis

  • The majority of children with contact dermatitis achieve good outcomes when first‑line management—combining allergen avoidance, appropriate topical corticosteroids, and aggressive moisturization—is employed. 37, 38

Diagnostic Evaluation and Assessment of Spongiotic Dermatitis

Diagnostic Challenges

  • Clinical morphology and distribution patterns are insufficient to reliably differentiate irritant contact dermatitis, allergic contact dermatitis, and atopic/endogenous dermatitis—especially on the hands and face—making detailed exposure history and patch testing essential. 40

Essential History Elements (for all suspected cases)

  • Obtain personal or family history of atopic disease (e.g., eczema, asthma, allergic rhinitis).
  • Document the initial site of symptom onset and subsequent spread pattern.
  • Identify relationships to specific products such as cosmetics, personal‑care items, topical medications, clothing, bandages, or gloves.
  • Record a complete inventory of all wash products, recognizing that many contain harsh emulsifiers/surfactants that can impair the skin barrier in predisposed individuals.
  • Explore associations with particular activities (e.g., hairdressing, home improvement, painting, sports).
  • Investigate occupational exposures, including detailed review of workplace products and safety data sheets.
  • Note symptom improvement during weekends/holidays and recurrence upon return to work.
  • Assess worsening after sunlight exposure.
  • Evaluate contact with primary skin irritants, including frequency of water exposure and specific products used.
    *These elements collectively improve diagnostic accuracy for spongiotic dermatitis. 40

Patch‑Testing Recommendations

  • Perform patch testing with an extended baseline series of allergens for any persistent or chronic dermatitis, as clinical features alone cannot reliably distinguish irritant, allergic, or endogenous causes. 40
  • Approximate annual patch‑testing workload: one technician per 700 individuals in the served population (e.g., 100 patch tests per year for a catchment of 70,000). 40
  • Antihistamines do not need to be discontinued before patch testing unless the test specifically evaluates urticaria or contact‑urticaria reactions. 40

Clinical Assessment Tools

  • Use validated instruments such as the Dermatology Life Quality Index (DLQI) and the Hand Eczema Severity Index (HECSI) for baseline assessment and monitoring treatment response. 40
  • A simplified Investigator’s Global Assessment (IGA) that evaluates induration, scaling, and fissuring (three variables) is quick to perform and useful for chronic hyperkeratotic hand dermatitis, but it is not appropriate for pompholyx‑type presentations. 40

Management of Hair‑Dye‑Induced Allergic Contact Dermatitis: Emollient Care and Safety Practices

Emollient and Barrier Restoration

  • Apply fragrance‑free, dye‑free moisturizers packaged in tubes (not jars) immediately after washing and reapply every 3–4 hours to maintain skin hydration and barrier function. American Academy of Dermatology recommendation. 41
  • Use the “soak‑and‑smear” method: soak the affected skin in plain water for about 20 minutes, then apply moisturizer to the still‑damp surface nightly for up to 2 weeks to enhance barrier repair. American Academy of Dermatology recommendation. 41

Protective Measures for Professionals with PPD Allergy

  • Hair‑care professionals who are sensitized to PPD should wear accelerator‑free neoprene or nitrile gloves and apply a moisturizer to the hands before donning gloves to reduce skin irritation. American Academy of Dermatology recommendation. 41

Avoidance of Topical Antibiotics as Primary Therapy

  • Do not prescribe topical antibiotics such as neomycin or bacitracin without a clear bacterial indication, because these agents are frequent contact allergens that can aggravate dermatitis. American Academy of Dermatology recommendation. 41

Patch Testing for Diagnosis of Facial Hair‑Dye Allergic Contact Dermatitis

Diagnostic Confirmation

  • Performing patch testing with an extended standard series of allergens is essential to definitively identify the causative sensitizer, because clinical appearance alone cannot reliably differentiate allergic from irritant contact dermatitis on the face. 42

Optimal Timing of Patch Test Readings

  • The most accurate interpretation of patch test results is achieved by reading the test at day 2 and day 4, and adding an additional reading at day 6–7, which captures approximately 10 % more positive reactions—particularly for allergens such as neomycin, nickel, and corticosteroids. 42

REFERENCES

22

drug allergy: a 2022 practice parameter update. [LINK]

Journal of Allergy and Clinical Immunology, 2022